Fluorescein diacetate (FDA) should not be used to study human carboxylesterase 2 (CES2) in complex biological systems without validation
Author:
Carolyn J. Karns,Anchal Singh,Makenzie R. Walk,Emmanuel Adusah,Alyssa M. Pearson,Samuel J. Knebel,Michael W. Beck
Publication:
Bioorganic & Medicinal Chemistry Letters
© 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.